fundament track assess
report adjust ep estim
consensu rais guidanc beat driven
primarili lower despit concern acuiti ramp partial off-set higher
expect sg indic strength across busi expect
posit momentum persist balanc year meanwhil
continu bullish commentari growth trajectori especi govern
program rais estim better view growth wait
anoth leg growth new pharmaci contract kick roll
forward po methodolog unchang po move new
ep vs prior ep reiter buy rate strong
momentum addit upsid potenti new pbm contract time
expect improv commerci growth head
remind commerci risk enrol neg impact hif
come back greater expect number client switch aso
compani character price environ competit ration
pre-tax margin target havent chang instead issu
provid full suit buydown opportun help keep custom risk product
respons roll initi better segment busi respond
chang market dynam quickli although initi didnt add
compani expect grow momentum growth retent head
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu antm opportun drive meaning medicar
advantag growth next sever year compani target doubl digit
organ growth driven improv star rate geograph expans improv group
posit new pharmaci contract overal antm growth target appear
achiev ep view stock attract risk/reward
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
net dbt
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest manag care
organ offer
commerci larg small employ medicar
medicaid individu market compani
oper cross shield plan
buy rate reflect view
valuat overli discount hc reform risk
undervalu compani growth profil
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu antm opportun drive meaning medicar
advantag growth next sever year compani target doubl digit
organ growth driven improv star rate geograph expans improv group
posit new pharmaci contract overal antm growth target appear
achiev ep view stock attract risk/reward
lay case mid-term doubl digit growth
significantli scale medicar oper last seven month
healthsun america choic deal compani see
opportun continu growth plan recent submit bid
mind view mid doubl digit organ membership growth achiev
near term believ maintain target margin
strong rate set stage continu growth
rate improv significantli last year obama-era cut
end republican sought stabl rate environ plan
industri rate exclud code trend well
chart rate time
star improv help growth
antm improv star rate help compani achiev doubl digit
growth outlook remind compani star higher get extra boost
rate give flexibl improv margin add extra benefit
acceler membership growth seen steadi improv star rate
past year compani improv percentag star plan
enrol estim improv alon ad
averag rate
chart star rate time
ad geographi target high acuiti dual
head open enrol estim base compani
counti exposur antm total address market grew y/i vs averag
howev still room upsid member access
plan latest open enrol highlight
acquisit remain part strategi market share gain adjac
counti expans present capit effici mean grow increas
penetr new market ad addit geographi help
drive averag growth next sever year
tabl address market base counti exposur
member access plan
total member begin open enrol
member access plan
meanwhil dual elig beneficiari anoth sourc industri growth
second largest medicaid manag compani appear well posit serv
market note antm medicaid presenc state give compani
competit advantag peer alreadi well establish provid
network market robust medic manag capabl ground
strong name brand local market
note sever recent group medicar win support optim expect
group busi doubl base cmss juli
enrol data appear recent group account roughli
live anthem medicar prefer ppo plan member flow
bonu elig contract spread geograph mostli ct ca overal
assum new busi oper target margin could add
tabl ep impact new group member
antm group growth trajectori key compani spread oper
cost across larger membership base achiev effici show
hypothet analysi antm scale drive lower sg spend per member
per month pmpm basi help bring compani target margin
new pharmaci contract anoth boost
part antm issu medicar weak pharmaci cost structur driven pbm
agreement esrx howev new pharmaci contract
antm cost structur result growth meaning improv first
busi see improv would medicar part structur
disadvantag given buy drug market grow part
modest addit growth start
howev bigger benefit may one first benefit plan
give senior cheap part plan simplist bid
versu benchmark provid extra benefit may abl
give part plan well vision dental hear coverag
expens part plan may abl give away part
benefit mismatch despit bid structur hurt antm
abil attract membership new pharmaci contract antm part price
drop might abl offer vision dental addit part without
chang bid creat attract benefit design stabl margin
improv growth outlook
conclus solid growth better cost structur
gener investor dont see well posit grow
compani made number invest appear pois pay exit
under-perform counti exit ineffici ppo product invest improv star
score strateg acquisit result antm commentari mid-teen
growth actual shouldnt surpris fact appear well
posit grow doubl digit next year take account
could deal supplement growth geograph expans improv star
rate improv cost structur new pharmaci benefit manag pbm
arrang grow group opportun help gain share
alreadi one best growth busi mco reiter buy
rate compani continu execut bullish outlook
next sever year upsid strong medicar growth
overview guidanc
histori conservat
note histor provid conserv guidanc beat rais
throughout year fact rais guidanc ytd vs ytd
consensu beat impli conservat expect upsid year goe
tabl initi guidanc compar actual result
adj ep rais
increas adjust ep guidanc least
impli year year growth least new outlook roughli line
fully-insur membership outlook lower member
expect million self-fund membership guidanc continu
million overal net enrol expect million
repres year year declin midpoint howev compani
maintain revenu outlook
rais tax rate guidanc basi point midpoint rais
dilut share guidanc million meanwhil compani increas
invest incom guidanc million due higher short-term interest rate
yield net line item larg off-set
re-affirmed oper cash flow sg cost trend outlook
note manag note see signific momentum busi
remaind compani move clear acceler
heel new pharmaci agreement regard medicar advantag
busi compani indic believ achiev mid-doubl digit
organ membership growth show strong margin
amort
po base ep estim premium histor
averag justifi believ rel high potenti upsid
estim stand-alone risk upsid better-than-expect
enrol growth stronger growth medicar advantag time enhanc
buyback interest rate hike well lt benefit new pbm agreement
risk downsid worse-than-expect membership growth rise cost trend
greater-than expect hc reform disrupt
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
